| Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals W Witte, M Kresken, C Braulke, C Cuny Clinical Microbiology and Infection 3 (4), 414-422, 1997 | 195 | 1997 |
| Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of … M Kresken, D Hafner, FJ Schmitz, TA Wichelhaus International journal of antimicrobial agents 23 (6), 577-581, 2004 | 136 | 2004 |
| Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin M Kresken, B Wiedemann Antimicrobial Agents and Chemotherapy 32 (8), 1285-1288, 1988 | 132 | 1988 |
| Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995 M Kresken, D Hafner, SGBR the Paul-Ehrlich Society for Chemotherapy: Infection 27 (suppl 2), 2-8, 1999 | 111* | 1999 |
| Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009) X Schleicher, PG Higgins, H Wisplinghoff, B Körber-Irrgang, M Kresken, ... Clinical microbiology and infection 19 (8), 737-742, 2013 | 101 | 2013 |
| The epidemiology of β-lactamases B Wiedemann, C Kliebe, M Kresken Journal of Antimicrobial Chemotherapy 24 (suppl_B), 1-22, 1989 | 97 | 1989 |
| Antimicrobial Resistance and Type Distribution of Streptococcus pneumoniae Isolates Causing Systemic Infections in Germany, 1992–1994 RR Reinert, A Queck, A Kaufhold, M Kresken, R Lütticken Clinical Infectious Diseases 21 (6), 1398-1401, 1995 | 92 | 1995 |
| The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia MI Gröschel, CJ Meehan, I Barilar, M Diricks, A Gonzaga, M Steglich, ... Nature communications 11 (1), 2044, 2020 | 90 | 2020 |
| Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum M Kresken, D Hafner, FJ Schmitz, TAS Wichelhaus | 86* | 2007 |
| Rationaler Einsatz oraler Antibiotika bei Erwachsenen: Empfehlungen einer Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. F VOGEL, H SCHOLZ, B Al-Nawas, W Elies, M Kresken, H Lode, O Müller, ... Medizinische Monatsschrift für Pharmazeuten 25 (6), 193-204, 2002 | 84* | 2002 |
| Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa M Kresken, D Hafner Chemotherapie Journal 5, 225-230, 1996 | 83 | 1996 |
| In Vitro Spectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions W Stubbings, P Leow, GC Yong, F Goh, B Körber-Irrgang, M Kresken, ... Antimicrobial agents and chemotherapy 55 (9), 4394-4397, 2011 | 77 | 2011 |
| Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries M Kresken, B Körber-Irrgang, DJ Biedenbach, N Batista, V Besard, ... Clinical Microbiology and Infection 22 (1), 63. e1-63. e5, 2016 | 76 | 2016 |
| Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum M Kresken, D Hafner, FJ Schmitz, TAS Wichelhaus Bericht über die Ergebnisse einer multizentrischen Studie der …, 2001 | 75 | 2001 |
| Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers FME Wagenlehner, F Münch, A Pilatz, B Bärmann, W Weidner, ... Antimicrobial agents and chemotherapy 58 (2), 713-721, 2014 | 72 | 2014 |
| Thirty years of VRE in Germany–“expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci G Werner, B Neumann, RE Weber, M Kresken, C Wendt, JK Bender, ... Drug Resistance Updates 53, 100732, 2020 | 71 | 2020 |
| Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin C von Eiff, RR Reinert, M Kresken, J Brauers, D Hafner, G Peters Journal of clinical microbiology 38 (8), 2819-2823, 2000 | 71 | 2000 |
| Prevalence of fluoroquinolone resistance in Europe M Kresken, D Hafner, B Wiedemann, H Mittermayer, L Verbist, ... Infection 22, S90-S98, 1994 | 69 | 1994 |
| Antimikrobielle Therapie der Sepsis KF Bodmann, F Vogel, W Graninger, M Kresken, WD Paar, G Peters, ... Chemotherapie Journal 10 (2), 43-55, 2001 | 68 | 2001 |
| Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa M Kresken, D Hafner Chemother J 9 (2), 51-86, 2000 | 64 | 2000 |
